Premium
Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drugs?
Author(s) -
Lo GinHo
Publication year - 2018
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.29794
Subject(s) - medicine , hepatocellular carcinoma , aspirin , hepatitis b , lamivudine , incidence (geometry) , hbeag , gastroenterology , risk factor , antiviral therapy , hepatitis c , cumulative incidence , clopidogrel , oncology , immunology , chronic hepatitis , hepatitis b virus , hbsag , virus , physics , transplantation , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom